| Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality JB van Rees, CJW Borleffs, MK de Bie, T Stijnen, L van Erven, JJ Bax, ... Journal of the American College of Cardiology 57 (5), 556-562, 2011 | 563 | 2011 |
| Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials JB Van Rees, MK de Bie, J Thijssen, CJW Borleffs, MJ Schalij, ... Journal of the American College of Cardiology 58 (10), 995-1000, 2011 | 393 | 2011 |
| Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients GH van Welsenes, JB van Rees, CJW Borleffs, SC Cannegieter, JJ Bax, ... Europace 13 (3), 389-394, 2011 | 142 | 2011 |
| The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications AC van der Heijden, CJW Borleffs, MS Buiten, J Thijssen, JB van Rees, ... Heart rhythm 12 (6), 1169-1176, 2015 | 123 | 2015 |
| Recurrent implantable cardioverter‐defibrillator replacement is associated with an increasing risk of pocket‐related complications C Jan Willem Borleffs, J Thijssen, MK de Bie, JB van Rees, ... Pacing and clinical electrophysiology 33 (8), 1013-1019, 2010 | 97 | 2010 |
| Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients CJW Borleffs, JB van Rees, GH van Welsenes, ET van der Velde, ... Journal of the American College of Cardiology 55 (9), 879-885, 2010 | 97 | 2010 |
| Cardiac device infections are associated with a significant mortality risk MK de Bie, JB van Rees, J Thijssen, CJW Borleffs, SA Trines, ... Heart Rhythm 9 (4), 494-498, 2012 | 89 | 2012 |
| Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer J Thijssen, CJW Borleffs, JB van Rees, SC Man, MK de Bie, J Venlet, ... Heart Rhythm 9 (4), 513-519, 2012 | 88 | 2012 |
| Improvements in 25 years of implantable cardioverter defibrillator therapy GH Van Welsenes, CJW Borleffs, JB Van Rees, JZ Atary, J Thijssen, ... Netherlands Heart Journal 19, 24-30, 2011 | 71 | 2011 |
| Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders J Thijssen, CJW Borleffs, V Delgado, JB van Rees, EAQ Mooyaart, ... Journal of the American College of Cardiology 58 (22), 2282-2289, 2011 | 70 | 2011 |
| Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES … JB van Rees, CJW Borleffs, GH van Welsenes, ET van der Velde, JJ Bax, ... Heart 98 (11), 872-877, 2012 | 64 | 2012 |
| Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice MK de Bie, J Thijssen, JB van Rees, H Putter, ET van der Velde, ... Heart 99 (14), 1018-1023, 2013 | 53 | 2013 |
| Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach J Thijssen, CJW Borleffs, JB van Rees, MK de Bie, ET van der Velde, ... European heart journal 32 (21), 2678-2687, 2011 | 49 | 2011 |
| Super‐responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment AC van der Heijden, U Höke, J Thijssen, CJW Borleffs, JB van Rees, ... European journal of heart failure 16 (10), 1104-1111, 2014 | 44 | 2014 |
| Early reperfusion therapy affects inducibility, cycle length, and occurrence of ventricular tachycardia late after myocardial infarction SRD Piers, AP Wijnmaalen, CJW Borleffs, CFB van Huls van Taxis, ... Circulation: Arrhythmia and Electrophysiology 4 (2), 195-201, 2011 | 44 | 2011 |
| Trans-venous lead removal without the use of extraction sheaths, results of> 250 removal procedures MK de Bie, DA Fouad, CJW Borleffs, JB van Rees, J Thijssen, SA Trines, ... Europace 14 (1), 112-116, 2012 | 42 | 2012 |
| Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients AC van der Heijden, J Thijssen, CJW Borleffs, JB van Rees, U Höke, ... Heart 99 (17), 1244-1249, 2013 | 38 | 2013 |
| Prophylactic implantable cardioverter–defibrillator treatment in the elderly: therapy, adverse events, and survival gain JB van Rees, CJ Willem Borleffs, J Thijssen, MK de Bie, L van Erven, ... Europace 14 (1), 66-73, 2012 | 38 | 2012 |
| The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice J Thijssen, JB van Rees, J Venlet, CJW Borleffs, U Höke, H Putter, ... Heart rhythm 9 (10), 1605-1612, 2012 | 37 | 2012 |
| Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back‐up after an event‐free first battery service‐life GH Van Welsenes, JB Van Rees, J Thijssen, SA Trines, L Van Erven, ... Journal of cardiovascular electrophysiology 22 (12), 1346-1350, 2011 | 36 | 2011 |
